Dimensional Fund Advisors
ANIX icon

Dimensional Fund Advisors’s Anixa Biosciences ANIX Stock Holding History

Dimensional Fund Advisors’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-17,544
Closed -$38.8K – 3352
2024
Q2 		$38.8K Sell
17,544
-3,633
-17% -$10.3K ﹤0.01% 3329
2024
Q1 		$66.1K Hold
21,177
– – ﹤0.01% 3312
2023
Q4 		$82.2K Hold
21,177
– – ﹤0.01% 3296
2023
Q3 		$69.2K Hold
21,177
– – ﹤0.01% 3353
2023
Q2 		$67.8K Hold
21,177
– – ﹤0.01% 3378
2023
Q1 		$91.1K Hold
21,177
– – ﹤0.01% 3316
2022
Q4 		$90 Hold
21,177
– – ﹤0.01% 3335
2022
Q3 		$104K Buy
+21,177
New +$85.8K ﹤0.01% 3322

Other funds holding ANIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MWM
Mission Wealth Management Santa Barbara, California $4.86B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors's ANIX Position: Q3 2024 in Review

Dimensional Fund Advisors sold out of Anixa Biosciences (ANIX) in Q3 2024, closing a stake of 17,544 shares — an estimated $38.8K sold.

Dimensional Fund Advisors first reported a position in ANIX in Q3 2022 and held it in 8 quarters. The position peaked at $104K in Q3 2022. 58 funds tracked by Wall St. Rank hold ANIX as of Q3 2024.

  • Dimensional Fund Advisors reported no remaining Anixa Biosciences position as of Q3 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 17,544 Anixa Biosciences shares in Q3 2024, an estimated $38.8K.
  • Dimensional Fund Advisors first reported a position in Anixa Biosciences in Q3 2022 and held it in 8 quarters.
  • Dimensional Fund Advisors's Anixa Biosciences position peaked at $104K in Q3 2022.
  • 58 funds tracked by Wall St. Rank held Anixa Biosciences as of Q3 2024.

Based on Dimensional Fund Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.